Back to Results
First PageMeta Content
Protease inhibitors / Hepatitis / Hepatology / Antivirals / Cytokines / Hepatitis C virus / Hepatitis C / Telaprevir / Boceprevir / Medicine / Biology / Health


Sofosbuvir for the Treatment of Hepatitis C and Evaluation of the 2014 American Association for the Study of Liver Diseases Treatment Guidelines May 2014
Add to Reading List

Document Date: 2014-06-12 12:40:34

Open Document

File Size: 1,59 MB

Share Result on Facebook

City

Portland / Medicaid Evidence / /

Company

Gilead Sciences Inc. / AbbVie Inc. / BOC / Agency for Healthcare Research / /

Country

United States / /

Event

FDA Phase / /

Facility

Science University / Drug Research Pipeline / /

/

IndustryTerm

Treatment of Hepatitis C / Liver Diseases Treatment / treatment of HCV / treatment protocols / HCV treatment / drug approval applications / Treatment for HCV / population accounting / /

MedicalCondition

HIV / liver failure / cirrhosis / Hepatitis C / hepatitis B / obesity / chronic HCV infection / liver disease / Medicaid infection / HCV genotype / Hepatic Fibrosis / Introduction Chronic hepatitis C / peripheral vascular disease / insulin resistance / disease / hepatocellular carcinoma / chronic liver disease / Liver Diseases / dyslipidemia / diabetes / HCV / metabolic syndrome / HCV infection / Virus Infection / Patients Who Develop Condition Chronic HCV infection / liver cancer / drug abuse / advanced fibrosis / infection / human immunodeficiency virus infection / chronic infection / HCV-RNA / /

MedicalTreatment

liver transplant / blood transfusions / treatment protocols / immunosuppression / organ transplant / /

Organization

National Institute of Health / United States Preventive Services Task Force / Center for Disease Control / MPH Center for Evidence-based Policy Suggested / Infectious Diseases Society of America / European Association for the Study of the Liver / Center for Evidence-based Policy / Oregon Health & Science University in Portland / American Association for the Study / US Food and Drug Administration / FDA / Policy Oregon Health & Science University / Center for Evidence-based Policy Oregon Health / US Department of Veterans Affairs / American Association for the Study of Liver Diseases Treatment Guidelines / Agency for Healthcare Research and Quality / /

Person

Martha Gerrity / Allison Leof / Valerie King / Payer Policies / /

/

Position

national leader / King / Private / /

Product

ribavirin / sofosbuvir / SVR12 / /

ProvinceOrState

Oregon / Connecticut / Florida / /

Technology

treatment protocols / Genotype / drug development / /

URL

www.ohsu.edu/policycenter / /

SocialTag